Protagonist Therapeutics Inc buy Jefferies Financial Group Inc.
Start price
02.02.26
/
50%
€70.50
Target price
02.02.27
€99.38
Performance (%)
19.15%
Price
16.03.26
€84.00
Summary
This prediction is currently active. The prediction currently has a performance of 19.15%. This prediction currently runs until 02.02.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 2.439% | 2.439% |
| iShares Core DAX® | -0,68 % | -4,85 % |
| iShares Nasdaq 100 | -0,03 % | 2,86 % |
| iShares Nikkei 225® | -0,54 % | -5,02 % |
| iShares S&P 500 | -0,21 % | 0,92 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Jefferies Financial Group Inc. from $95.00 to $118.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat